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Abstract
We report the proteomic and antivenomic characterization of Crotalus tigris venom. This venom
exhibits the highest lethality for mice among rattlesnakes and the simplest toxin proteome reported
to date. The venom proteome of C. tigris comprises 7–8 gene products from 6 toxin families: the
presynaptic β-neurotoxic heterodimeric PLA2, Mojave toxin, and two serine proteinases comprise,
respectively, 66% and 27% of the C. tigris toxin arsenal, whereas a VEGF-like protein, a CRISP
molecule, a medium-sized disintegrin, and 1–2 PIII-SVMPs, each represents 0.1–5% of the total
venom proteome. This toxin profile really explains the systemic neuro- and myotoxic effects
observed in envenomated animals. In addition, we found that venom lethality of C. tigris and other
North American rattlesnake type II venoms correlates with the concentration of Mojave toxin A-
subunit, supporting the view that the neurotoxic venom phenotype of crotalid type II venoms may
be described as a single-allele adaptation. Our data suggest that the evolutionary trend towards
neurotoxicity, which has been also reported for the South American rattlesnakes, may have
resulted by paedomorphism. The ability of an experimental antivenom to effectively
immunodeplete proteins from the type II venoms of C. tigris, C. horridus, C. oreganus helleri, C.
scutulatus scutulatus, and S. catenatus catenatus, indicated the feasibility of generating a pan-
American anti-Crotalus type II antivenom, suggested by the identification of shared evolutionary
trends among South American and North American Crotalus.
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INTRODUCTION
Crotalus tigris, the tiger rattlesnake, is a ground-dwelling, medium-sized pitviper (the
largest specimen on record measured 88.5 cm1). The monotypic C. tigris is found in isolated
populations in rocky habitats or in mesquite grasslands at elevations of near sea level to
about 1400 m, in southwestern United States (central, south-central, and extreme
southeastern Arizona), extending southward into northwestern Mexico (Sonoran
Desertscrub, Chihuahuan Desertscrub, Interior Chaparral, and Madrean Evergreen
Woodland), and on Isla Tiburón in the Gulf of California1–3. 35–52 irregular, grey or
brownish diffuse dorsal crossbands (“tiger bands”), and the pink to lavender tinge of its
body distinguish the tiger rattlesnake from other species of rattlesnakes which occur within
some areas of its range, C. atrox, C. cerastes, C. mitchellii, C. molossus, and C. scutulatus3.
C. tigris has a very small triangular head relative to the size of the body and a large rattle,
which can make a lot of sound, reaching a loudness of about 77 dB4
(http://www.californiaherps.com/noncal/southwest/swsnakes/pages/c.tigris.html).
Little is known about the natural history of the C. tigris. It is chiefly nocturnal during the hot
summer months, diurnal and crepuscular in fall, and hibernates over the cold months of late
fall and winter in rock crevices or animal burrows1–3. In spite of being a ground-dwelling
inhabitant of the desert, its activity is not restricted to the ground. It swims readily and also
has been found in bushes 60 cm above the floor1. The tiger rattlesnake ambushes much of its
prey but also active forages small rodents and lizards2,5, juveniles relying heavily on lizards
and adults depending more on rodents. In addition, these small rattlesnakes have been
known to eat fairly large prey, including kangaroo rats, packrats, and even spiny lizards6.
This is based upon its venom’s high lethality, rated the highest of all rattlesnake venoms
(LD50 value for mice is 0.07 mg/kg intraperitoneal, 0.056 mg/kg intravenous, and 0.21 mg/
kg subcutaneous)7–9.
Approximately 7,000–8,000 reptile bites are reported to the American Association of Poison
Control Centers (AAPCC) each year10,11. Most bites result from the eastern diamondback
rattlesnake (C. adamanteus), the western diamondback rattlesnake (C. atrox), the prairie and
Pacific rattlesnakes (C. viridis), the timber rattlesnake (C. horridus), and the pygmy
rattlesnake (S. miliarius), when a snake is handled or abused. The eastern and western
diamondback rattlesnakes account for the most fatalities. Human bites by C. tigris are
infrequent, and literature available on bites by this snake is scarce. The several recorded
human envenomations by tiger rattlers produced little local pain, swelling, or other reaction
following the bite, and despite the toxicity of its venom no significant systemic
symptoms12,13. The comparatively low venom yield (6.4–11 mg dried venom) and short
4.0–4.6 mm fangs1,2 of C. tigris possibly prevent severe envenoming in adult humans.
However, the clinical picture could be very more serious if the person bitten was a child or a
slight build individual. The early therapeutic use of antivenom is important if significant
envenomation is suspected. The purpose of this report was to characterize the venom toxin
proteome of the tiger rattlesnake, establish composition-toxicity correlations, and investigate
the immunoreactivity profile of an experimental and a commercial antivenom.
EXPERIMENTAL SECTION
Venoms and antivenoms
The venoms of adult C. tigris (Tiger rattlesnake), C. horridus (Timber rattlesnake), C.
scutulatus scutulatus type A (Mohave rattlesnake), and C. oreganus helleri (Southern
Pacific rattlesnake) were extracted from specimens kept in captivity in the serpentarium of
the National Natural Toxins Research Center (Kingsville, TX, http://ntrc.tamuk.edu) by
biting on a parafilm-wrapped container.
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The anti-crotalic antivenom used for in vivo neutralization assays study was produced at
Instituto Butantan (But, São Paulo, Brazil, http://www.butantan.gov.br) by
hyperimmunization of horses with a pool of equal amounts of C. d. terrificus and C. d.
collilineatus venoms collected in Southeastern and Midwestern Brazil, in the states of São
Paulo, Mato Grosso and Minas Gerais (Marisa Maria Teixeira da Rocha, Instituto Butantan,
personal communication). The antivenom comprise purified F(ab′)2 fragments generated by
pepsic digestion of ammonium sulphate-precipitated IgGs. F(ab′)2 concentration was
determined spectrophotometrically using an extinction coefficient (ε) of 1.4 for a 1mg/ml
concentration at 280 nm using a 1cm light pathlength cuvette14.
An experimental antiserum was raised in rabbits by subcutaneous injections of sublethal
amounts of a mixture of venoms from C. d. terrificus, C. simus, and C. lepidus lepidus. First
injection comprised 100 μg venom in 100 μl of PBS (20 mM phosphate, 135 mM NaCl, pH
7.3) emulsified with an equal volume of Freund’s complete adjuvant. Booster injections
comprising increasing amounts (200–500 μg) of immunogen emulsified in Freund’s
incomplete adjuvant were administered every 2 weeks for a period of 2–3 month (depending
on the titer of the antiserum determined by a standard ELISA procedure). Terminal cardiac
blood collection, done by intracardiac puncture performed under general anesthesia, was
approved by the IBV’s Ethics Commission. The IgG fraction was purified by ammonium
sulphate precipitation followed by affinity chromatography on Sepharose-Protein A
(Agarose Bead Technologies, Tampa, FL, USA) following the manufacturer’s instructions.
Venomics
Venom proteins were separated by reverse-phase HPLC using a Teknokroma Europa C18
(0.4 cm × 25 cm, 5 μm particle size, 300 Å pore size) column as described15. Protein
detection was at 215 nm and peaks were collected manually and dried in a Speed-Vac
(Savant). The relative abundances (% of the total venom proteins) of the different protein
families in the venoms were estimated from the relation of the sum of the areas of the
reverse-phase chromatographic peaks containing proteins from the same family to the total
area of venom protein peaks. In a strict sense, and according to the Lambert-Beer law, the
calculated relative amounts correspond to the “% of total peptide bonds in the sample”,
which is a good estimate of the % by weight (g/100g) of a particular venom component. The
relative contributions of different proteins eluting in the same chromatographic fraction were
estimated by densitometry after SDS-PAGE separation.
HPLC fractions were analyzed by SDS-PAGE (using 15% polyacrylamide gels) and N-
terminal sequencing (using a Procise instrument, Applied Biosystems, Foster City, CA,
USA). Amino acid sequence similarity searches were performed against the available
databanks using the BLAST program16 implemented in the WU-BLAST2 search engine at
http://www.bork.embl-heidelberg.de. In some cases, this information is sufficient to assign a
venom toxin to a protein family represented in the databases. Molecular mass determination
was performed by MALDI-TOF mass spectrometry (using an Applied Biosystems Voyager-
DE Pro™ instrument) and electrospray ionization (ESI) mass spectrometry (using an
Applied Biosystems QTrap™ 2000 mass spectrometer). Protein bands of interest were
excised from Coomassie Brilliant Blue-stained SDS-PAGE gels and subjected to automated
reduction, alkylation, and in-gel digestion with sequencing grade porcine pancreatic trypsin
(Promega). The tryptic peptide mixtures were dried in a SpeedVac and dissolved in 5 ml of
50% ACN and 0.1% TFA. 0.85 ml of digest were spotted onto a MALDI-TOF sample
holder, mixed with an equal volume of a 1:10 (v/v) dilution of a saturated solution of α-
cyano-4-hydroxycinnamic acid (Sigma) in 50% ACN containing 0.1% TFA, dried, and
analyzed with an Applied Biosystems Voyager-DE Pro MALDI-TOF mass spectrometer,
operated in delayed extraction and reflectror modes. For peptide ion sequencing, the protein
digest mixtures were loaded in nanospray capilars (http://www.proxeon.com) and submitted
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to electrospray ionization mass spectrometric analysis using an Applied Biosystem’s QTrap
2000 mass spectrometer. Enhanced Multiply Charged mode was run at 250 amu/s across the
entire mass range to determine the charge state of the ions. Monoisotopic doubly- or triply-
charged precursor ions were selected (within a window of ± 0.5 m/z) and sequenced by
CID-MS/MS using the Enhanced Product Ion mode with Q0 trapping option; Q1 was
operated at unit resolution, the Q1-to-Q2 collision energy was set to 30 (for m/z ≤ 700) or
35 eV (for m/z > 700), the Q3 entry barrier was 8 V, the LIT (linear ion trap) Q3 fill time
was 250 ms, and the scan rate in Q3 was 1000 amu/s. CID spectra were interpreted manually
(i.e. de novo sequenced) or using MASCOT as a seach engine, either through its public-
available website (http://www.matrixscience.com), or using a licensed version (2.0) of the
MASCOT program. Searches were done against the default non-redundant datababes or a
private database containing 1763 viperid protein sequences deposited in the SwissProt/
TrEMBL database (http://www.uniprot.org/) plus the previously assigned peptide ion
sequences from snake venomics projects carried out in our laboratories15,17. MS/MS mass
tolerance was set to ± 0.6 Da. Carbamidomethyl cysteine and oxidation of methionine were
fixed and variable modifications, respectively.
Neutralization of venom lethality
To assess the ability of the anticrotalic antivenom produced at Instituto Butantan to
neutralize the lethal activity of C. tigris venom, five mice received an i.p. injection of a
venom challenge dose of 5 μg (~ 4 LD50 for mice of 16–18 g body weight) in 250 μl of
phosphate-buffered saline (0.12 M NaCl, 0.04 M sodium phosphate, pH 7.2). An
intraperitoneal (i.p.) median lethal dose (LD50) of 0.07 μg/g body weight was assumed9.
Another group of five mice received an identical injection of venom that had been
preincubated with the antivenom, at a ratio of 4 μl antivenom/μg venom, for 30 min at room
temperature. Deaths were scored after a period of 48 hr.
Antivenomics
For antivenomics17, 1 mg of crude C. tigris venom in 300 μl of 0.2 M phosphate, pH 7.0,
was incubated overnight at room temperature and with gentle stirring with 10 mg of rabbit
IgG antibodies affinity-purified from the antiserum raised against a mixture of venoms from
C. d. terrificus, C. simus, and C. lepidus lepidus. IgG-antigen immunocomplexes were
pulled down with Agarose-Protein-A (ABT) beads capable of retaining 25 mg of IgG
molecules. After centrifugation at 13,000 rpm for 3 min in an Eppendorf centrifuge, the
supernatant containing the non-bound venom proteins was submitted to reverse-phase
separation as described above. Control samples were subjected to the same procedure except
that (i) pre-immune rabbit serum IgGs were employed, or (ii) antivenom IgGs were not
included in the reaction mixture.
RESULTS AND DISCUSSION
The minimalist venom proteome of C. tigris suggests that neurotoxicity represents a
paedomorphic trend in Neartic type II venoms
Rattlesnake venoms belong to one of two distinct phenotypes, which broadly correspond to
type I (high levels of SVMPs and low toxicity, LD50 >1 mg/g mouse body weight) and type
II (low metalloproteinase activity and high toxicity, LD50 <1 mg/g mouse body weight)
defined by Mackessy18,19. The high toxicity of type II venoms and the characteristic
systemic neuro- and myotoxic effects observed in envenomations appear to be directly
related to the high concentration of the presynaptic β-neurotoxic heterodimeric PLA2
molecules in these venoms. The venom proteome of C. tigris appears to be composed by
only 7–8 gene products from 6 different toxin families (Table 1, Figs. 1 and 2). In particular,
the low metalloproteinase content, the high concentration of Mohave toxin subunits (66% of
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the total venom proteins) (Table 2), and its high toxicity, LD50 0.05 (i.v)-0.07 (i.p.) mg/g
mouse body weight, which is the highest known for any rattlesnake venom7–9, place C.
tigris venom into the type II class defined by Mackessy18,19. This is by far the simplest
viperid snake venom toxin proteome reported to date. Hence, most snake venoms of family
Viperidae (vipers and pitvipers) analyzed by state-of-the-art proteomic tecniques comprise
several tens to some hundreds of molecules.17,20–26 Cerberus rynchops venom represents
another very low complexity proteome. It appears to contain a total of five major proteins,
one isoform each of metalloproteinase, CRISP and C-type lectin and two major isoforms of
ryncolins.27 C. rynchops (dog-faced water snake) belongs to Homalopsidae of Colubroidea
(rear-fanged snakes). The pharmacological profile of C. rynchops venom remains elusive,
but given the central role that diet has played in the adaptive radiation of snakes28–30, venom
may represent a key trophic adaptative trait.31 In the frame of this view, the relative
composition of C. tigris venom (Table 2) suggests that the pharmacological relevance of its
toxins may vary widely: the two subunits of Mojave toxin and two serine proteinases
comprise, respectively, 66% and 27% of the C. tigris toxin arsenal, whereas a VEGF-like
protein, a CRISP molecule, a medium-sized disintegrin, and 1–2 PIII-SVMPs, each
represents 0.1–5% of the total venom proteome (Table 2).
The toxin profile of C. tigris venom may explain the effects observed in envenomated
animals8,32. Mice injected s.c. with C. tigris venom characteristically showed circling
movements, ataxia, and flaccid paralysis. Local subcutaneous hemorrhage was not observed
except with doses about ten times the LD50%. In addition, although the venom exhibits low,
but significant protease activity, it does not seem to cause any hemolytic activity. These
systemic neuro- and myotoxic effects appear to be directly related to the concentration of the
presynaptic β-neurotoxic heterodimeric PLA2 molecules, Mojave toxin (in Neartic
rattlesnakes)33, crotoxin (in Central and South American rattlesnake venoms)34–36, and
sistruxin (in Sistrurus catenatus catenatus and S. c. tergeminus venoms)37,38. The
occurrence of high concentration of a toxin immunologically related to Mojave toxin in C.
tigris venom had been reported by Weinstein et al.39, and subsequently the presence of
Mojave toxin subunits A and B in C. tigris was verified using DNA analysis of blood and
toxin specific immunological analysis of venom40. Hawgood41 compiled a review of
pathophysiological effects of Mojave toxin: Castinolia et al.42 demonstrated inhibition of
neuromuscular transmission, and Ho and Lee43 and Gopalakrishnakone et al.44 found the
site of action to be presynaptic and also described the toxin as myonecrotic and capable of
causing pulmonary hemorrhage. Mice injected with the isolated toxin at a dosage of about
the LD50 level of crude venom displayed ataxia and a short period of hyperexcitability,
which were followed by prostration and tachypnea. Extensive respiratory distress occured
rapidly and led to death within 15 min postinjection39. This pattern of pharmacological
activities resembles the symptoms observed in envenomings by South American rattlesnakes
(Crotalus durissus sp.), characterized by severe systemic effects associated with
neurotoxicity and systemic myotoxicity45,46.
C. tigris also exhibits a toxin venom profile and lethal median toxicity (LD50) closely
resembling those of neurotoxic South American Crotalus durissus subspecies (terrificus,
cascavella, collilineatus)47,48 (compare Fig. 1 and panel D of Fig. 3; Table 3). Moreover,
reverse-phase HPLC profiling of the venoms from C. scutulatus scutulatus (Css, Mohave
rattlesnake), C. horridus (Ch, Timber rattlesnake), and the Southern Pacific rattlesnake, C.
oreganus helleri (Coh), displayed in Figure 3 highlights the occurrence of Mojave toxin
subunits in these New World rattlesnakes and shows the close resemblance between North
American type II and neurotoxic South American crotalid venoms. Mojave toxin molecules
isolated from these taxa exhibit identical N-terminal sequences (A-subunit,
SSYGCYCGAGGQGWP + SPENCQGESQPC; B-subunit, HLLQFNKMIKFETRK) and
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very similar electrospray-ionization isotope-averaged molecular masses (A-subunits, 9 kDa;
B-subunits: 14186 Da (Css), 14156 Da (Ch), 14177 Da (Coh); 14187 Da (Cdc)).
Rattlesnakes had its origin ~20 Mya in the Sierra Madre Occidental in the north-central
Mexican Plateau49, and dispersed northward into North America and southward into South
America1,3. Gain of neurotoxicity and lethality to rodents represents a paedomorphic trend
that correlates with increased concentration of crotoxin along the axis of Crotalus radiation
in South America47,48. The phylogeny and evolution of β-neurotoxic PLA2s present in the
venoms of rattlesnakes has been investigated by Werman49. The distribution of the highly
closely related Mojave toxin resembles a mosaic from Mexico northward50. The lack of
phylogenetic clustering among rattlesnakes with neurotoxin PLA2 molecules in their
venoms (Fig. 4) indicates that phylogeny may not be an important consideration in the
evolution of rattlesnake type II venoms51. The distribution of Mojave toxin varies not only
between species, but also between geographic populations within the same species51. Powell
and Lieb52 have suggested that the extremely high neurotoxicity exhibited by North
American rattlesnakes represents a transitory populational phenomenon associated with
novel prey bases.
The evolution of rattlesnakes in the warm deserts of western North America has been
investigated by evaluating mitochondrial DNA (mtDNA) sequences53. The most recent
common ancestor for the rattlesnakes Sistrurus/Crotalus was estimated at 12.7 Mya (mid-
Miocene), the subsequent divergence of S. miliarius anbd S. catenatus sp. appears to have
occurred 10.2 Mya, and C. tigris seemingly diverged from C. mitchellii at the Late Miocene/
Early Pliocene boundary (5.6 Ma)53. On the other hand, Wüster and co-workers54 have
traced the dispersal of C. durissus in South America, revealing a classical pattern of
stepwise colonization progressing from a northern center of origin in Mexico to northern
South America and across the Amazon Basin. The biogeographical data suggested an
ancient basal cladogenesis in the Central American C. simus clade dated back to the late
Miocene/early Pliocene (6.4–6.7 Mya), and a relatively recent (1.7–1.1 Mya) basal South
American dispersal across a central trans-Amazonian corridor during the middle Pleistocene
(1.1–1.0 Mya)54,55. The timing of these cladogenetic events yielding taxa with type II
venoms scattered through the phylogenetic tree of the rattlesnakes (Fig. 4) may reflect the
convergence of an evolutionary trend towards neurotoxicity. Assuming that the evolutionary
trend reported for the South American rattlesnakes47,48 holds true for the North American
Crotalus species, the occurrence of Mojave toxin in the venom of adults specimens of
certain populations within terminal clades of recently divergent North American taxa (Fig.
4) may also have resulted by paedomorphism. Furthermore, and taking for granted that
experimental verification is required (e.g. through comparative proteomic analysis of
neonate and adult venoms), the reported ontogenetic variation in the venom composition of
North American rattlesnakes55,56, would support this hypothesis. Of note is that neonate,
juvenile, and adult C. o. concolor venoms are essentially similar in composition, with
respect to toxicity, amount of concolor toxin (PLA2), and low metalloproteinase activity55.
Venom lethality in North American rattlesnake type II venoms correlates with
concentration of Mojave toxin A-subunit
The relative abundances of the Mojave toxin (or crotoxin) A- and B-subunits in the
proteomes of type II venoms were estimated from the areas of their reverse-phase
chromatographic peaks (Table 3). In line with the fact that these neurotoxic PLA2s are
composed of a non-toxic acidic (A-) 3-chain subunit, derived from the proteolytic cleavage
of a single PLA2 precursor molecule, and a mildy toxic basic (B-), single-chain PLA2
subunit that associate noncovalently into dimers, increasing thereby the toxicity 10–30
times33–35, there is a clear correlation between heterodimeric Mojave toxin (or crotoxin)
concentration and the reported venom LD50 (Table 3). In the venoms sampled in this work,
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the B-subunit was present in 2.1–4.5-fold excess with respect to the A-subunit, suggesting
that translation into the venom of the acidic subunit is the limiting factor for confering
enhanced venom neurotoxicity. In line with this view, the Mojave toxin B-subunit gene is
widespread among Crotalus species, and its occurrence is independent of the A-subunit
gene51–53. The neurotoxic venom phenotype may thus be described as a single-allele (A-
subunit) adaptation51,52. This view is supported by previous reports showing that Mojave
rattlesnakes (Crotalus scutulatus scutulatus) lacking the acidic subunit DNA sequence lack
Mojave toxin in their venom57.
Antivenomics of C. tigris and other crotalid type II venoms
The evolutionary trend towards neurotoxicity observed in South American and North
American rattlesnakes suggested the feasibility of generating a pan-American anti-crotalid
type II venoms. To check this possibility, we first assessed the ability of the anticrotalic
antivenom produced at Instituto Butantan against C. d. terrificus venom to neutralize the
lethal activity of C. tigris venom. This antivenom showed a very high effectiveness in the
neutralization of the lethal, myotoxic, and neurotoxic effects of the crotoxin-rich venoms of
C. durissus subspecies and newborn C. simus58. All five mice receiving an intraperitoneal
injection of ~ 4 LD50 of venom died within 16 h, whereas all mice that received the venom/
antivenom mixture survived throughout the 48 h observation period, demonstrating that the
Butantan anti-C. d. terrificus antivenom is also able to neutralize the lethal action of C. tigris
venom. Next, we applied our antivenomics protocol17,59,60 to assess the ability of an
experimental (C. simus, C. l. lepidus, C. d. terrificus) antivenom to immunodeplete proteins
from the venoms of C. tigris, C. horridus, C. oreganus helleri, C. scutulatus scutulatus, and
S. catenatus catenatus. The results, illustrated in Fig. 5, clearly showed that the trivalent
antivenom was very effective targeting the toxins of these type II venoms.
Concluding remarks and perspectives
The characterization of the venom of C. tigris and finding of largely conserved toxin profile
in the venoms of other neurotoxic North American rattlesnakes provides a proteomic
framework to interpret previous biochemical, immunochemical, and pharmacological
investigations on crotalid type II venoms. Of particular relevance is the correlation between
the translational level of Mojave toxin A-subunit and venom lethal activity. In addition, the
crystal structure of crotoxin from C. d. terrificus, recently solved at 1.35 Å resolution,
indicates that posttranslational cleavage of the acidic subunit precursor is a prerequisite for
the assembly of the heterodimeric β-neurotoxin61. However, the identity of the protease
responsible for the proteolytic processing of the acidic subunit precursor of neurotoxic PLA2
complexes, Mojave toxin and crotoxin, remains elusive. Whether any of the two serine
proteinases present in C. tigris venom bears this activity deserves further investigation.
Our antivenomic results and the lack of phylogenetic clustering among rattlesnakes with
neurotoxin PLA2 molecules in their venoms (a paedomorphic trend?) strongly indicate that
proteomic-guided identification of evolutionary and immunological trends among venoms
may aid replacing the traditional geographic- and phylogenetic-driven hypotheses for
antivenom production strategies by a more rationale approach based on venom proteome
phenotyping and immunological profile similarities. In this respect we predict that the
neurotoxic venoms of C. lepidus klauberi and C. mitchelli mitchelli may exhibit the
proteomic and evolutionary trends outlined here for type II Crotalus venoms. The
identification of shared evolutionary trends among South American and North American
Crotalus reported here may impact the choice of venoms for immunization to produce an
effective pan-American anti-Crotalus antivenom.
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Synopsis
• Crotalus tigris, the deadliest rattlesnake, possesses a minimalist venom.
• Neurotoxicity of C. tigris venom correlates with its Mojave A-subunit content.
• The trend towards neurotoxicity may represent a paedomorphic trait.
• A trivalent antivenom efficiently immunodepletes type II venom toxins.
• Evolutionary and immunological trends may aid generating an effective pan-
American anti-Crotalus antivenom.
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Fig. 1. Characterization of the venom proteome of Crotalus tigris
Reverse-phase HPLC separation of the venom proteins of C. tigris. Insert, SDS-PAGE of
the reverse-phase HPLC separated venom proteins run under reduced conditions. Molecular
mass markers (in kDa) are indicated at the side of each gel. Protein bands were excised and
characterized by mass fingerprinting and CID-MS/MS of selected doubly- or triply-charged
peptide ions (Table 1).
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Fig. 2. Overall protein composition of the venoms of C. tigris
Relative occurrence of proteins from different toxin families in the venoms of adult C. tigris.
PIII-SVMP, snake venom Zn2+-metalloproteinase (SVMPs) of class III; CRISP, cysteine-
rich secretory protein; svVEGF, snake venom vascular endothelial growth factor. For details
of the individual proteins characterized consult Table 1. The percentages of the different
toxin families in the venoms are listed in Table 2.
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Fig. 3. Comparison of the toxin profiles of type II venoms
The venom proteins of C. scutulatus scutulatus (type A) (panel A), C. oreganus helleri (B),
C. horridus (C), and C. durissus cascavella (D) were separated by reverse-phase HPLC.
Peaks containing the acidic and the basic subunits of neurotoxin Mojave toxin or crotoxin
are labelled “a” and “b”, respectively. Insert, electrospray-ionization mass spectra of the
neurotoxin B-subunits.
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Fig. 4. Phylogenetic distribution of rattlesnake type II venoms
Taxa confirmed for the presence of neurotoxic PLA2 complexes (sistruxin, crotoxin,
canebrake toxin, Mojave toxin, concolor toxin) in their venoms are boxed in gray
background. The cladogram, based on Castoe and Parkinson65, shows taxonomic
relationships among rattlesnakes (Crotalus and Sistrurus) and highlights the lack of
phylogenetic clustering among species with neurotoxin molecules in their venoms.
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Fig. 5. Immunodepletion of venom proteins by an experimental antivenom
Reverse-phase separations of the venom proteins (upper chromatograms) from C. tigris (A),
C. horridus (B), C. oreganus helleri (C), C. scutulatus scutulatus (type A) (D), and S.
catenatus catenatus (E), and the toxins recovered after incubation of the crude venoms with
the experimental trivalent antivenom against C. simus, C. l. lepidus, C. d. terrificus (lower
chromatograms), followed by immunoprecipitation with Agarose-Protein A.
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TABLE 2
Overview of the relative occurrence of proteins (in percentage of the total HPLC-separated proteins of the
different families) in the venom of Crotalus tigris.
Protein family % of total venom proteins
Mojave toxin 66.2
 • acid chain 22.1
 • basic chain 44.1
Serine proteinase 26.8
svVEGF 5.0
CRISP 1.9
Disintegrin 0.2
PIII-SVMP 0.1
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TABLE 3
Correlation between intraperitoneal median lethal toxicity (LD50, in mg venom/g mouse) and relative
abundance (in percentage of the total HPLC-separated proteins) of Mojave toxin or crotoxin subunits (Figs. 1
and 3) in the venom proteomes of crotalid species. %AB, estimated percentage of AB heterodimer.
A-chain B-chain %AB LD50
C. oreganus helleri 2 9 22 1.518
S. catenatus catenatus 3.6 12.8 28 0.13–0.4330
C. scutulatus scutulatus (A) 4.5 19 24 0.22–0.4662
C. oreganus concolor 21 0.4618
C. horridus 7 22 32 0.22–1.063
C. durissus collilineatus 17 50 34 0.07–0.164
C. durissus terrificus 19 40.5 46 0.06–00964
C. durissus cascavella 20 52.5 39 0.07–0.164
C. tigris 21 45 46 0.05–0.077–9
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